NRX Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nrx Pharmaceuticals, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.839 Hello and welcome to the BIT Digital first quarter 2026 earnings 00:00:05.839 -- 00:00:08.022 conference call. 00:00:08.022 -- 00:00:13.229 We'll begin shortly. During the call, all participant lines will be in listen-only 00:00:13.229 -- 00:00:19.458 mode. Following management's remarks, we'll open the line for questions. 00:00:19.458 -- 00:00:24.905 If you would like to ask the question at that time, please press star 1 on your telephone 00:00:24.905 -- 00:00:26.547 keypad. 00:00:26.547 -- 00:00:30.035 As a reminder, today's call is being recorded. 00:00:30.035 -- 00:00:35.282 I'll now turn the call over to your host, Daniel Kennedy, Head of Investor 00:00:35.282 -- 00:00:40.647 Relations at BitDigital. Daniel, please go ahead. 00:00:42.993 -- 00:00:48.141 Thank you, and welcome everyone to BitDigital's first quarter 2026 earnings 00:00:48.141 -- 00:00:53.749 call. Joining me today are Sam Tabar, our Chief Executive Officer, 00:00:53.749 -- 00:00:57.524 and Eric Huang, our Chief Financial Officer. 00:00:57.524 -- 00:01:02.852 I'd like to remind everyone that certain statements made during today's call may be forward-looking. 00:01:02.852 -- 00:01:08.220 These statements are subject to risks and uncertainties that could cause results to differ. 00:01:08.220 -- 00:01:13.067 For a discussion of these risks, please refer to our SEC filings, including our Form 00:01:13.067 -- 00:01:16.089 10Q filed today. 00:01:16.172 -- 00:01:20.298 Throughout the call, we may also refer to non-GAAP financial measures. 00:01:20.298 -- 00:01:25.185 Reconciliations to the most direct comparable GAAP measures can be found in our earnings 00:01:25.185 -- 00:01:28.321 materials available on our website. 00:01:28.321 -- 00:01:34.127 Unless otherwise indica...